How to Evaluate Patients Taking Compounded GLP-1 Medications When a patient presents using a compounded GLP-1 product, the initial conversation should remain nonjudgmental
GLP-1 medications influence multiple metabolic pathways, including insulin secretion, glucose regulation, and energy expenditure
Other patients with a BMI of 27 or higher and who are dealing with conditions like Type 2 diabetes, hypertension, or sleep apnea may also benefit from semaglutide to lose weight and improve these conditions
Compounded GLP-1s are not FDA-approved products
Weight Loss Journey Weight loss surgery interferes with the bodys ability extract Vitamin B-12 from food, resulting in low B-12 levels
In the pancreas, these medications enhance glucose-dependent insulin secretion and suppress inappropriate glucagon release, thereby improving glycemic control